Literature DB >> 23312121

Is preoperative chemoradiation with paclitaxel and carboplatin a new standard of treatment for esophageal cancer?

Antoine Adenis1, Xavier Mirabel, Christophe Mariette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23312121     DOI： 10.1016/j.ijrobp.2012.11.021

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  2 in total

1.  Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients.

Authors:  Cui-Ying Zhang; Juan Zhang; Yun-Fan Ma; Hong Zhe; Ren Zhao; Yan-Yang Wang
Journal:  Dis Markers       Date:  2019-08-14       Impact factor: 3.434

2.  Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.

Authors:  Mathieu Messager; Xavier Mirabel; Emmanuelle Tresch; Amaury Paumier; Véronique Vendrely; Laetitia Dahan; Olivier Glehen; Frederique Vasseur; Thomas Lacornerie; Guillaume Piessen; Farid El Hajbi; William B Robb; Stéphanie Clisant; Andrew Kramar; Christophe Mariette; Antoine Adenis
Journal:  BMC Cancer       Date:  2016-05-18       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.